Cancer Horizons logo
Select a Cancer Type:

Breast

Patients With Cancer Should Speak Up About Mental Health Struggles if They Don’t Feel Heard, Expert Says

Video

A psychiatrist advises patients with cancer to speak up about their mental health concerns during cancer treatment, as there are tools that can guide best next steps.

Patients with cancer who have mental health struggles during treatment should not wait to reach out to their health care providers, according to Dr. Wendy Baer, a psychiatrist at the Winship Cancer Institute at Emory University in Atlanta.

Baer explained that clinicians have tools that they should be utilizing to measure levels of distress that patients are going through, such as the National Comprehensive Cancer Network’s Distress Thermometer, which measures physical concerns — such as pain, sleep issues and changing in eating habits — as well as emotional, social, practical and spiritual concerns.

Once clinicians better understand the feelings that patients are experiencing, they may be able to recommend seeing a therapist, joining a support group or another method to help manage the distress.

READ MORE: Addressing Psychosocial Needs in Cancer Care Has Improved Over Past 20 Years, But More Work Still Needed

Transcription:

I think if people are getting treated in a place where they don't feel heard, or that some of their emotional concerns aren't getting addressed, it's worth bringing up. It's worth talking about with your (health care) team and see if you start a conversation if they can go anywhere.

There are guidelines for managing emotional states in cancer, and they're put out by the National Comprehensive Cancer Network. The instrument we use to measure emotional well-being and cancer is called the Distress Thermometer. And so that is actually recommended to be used in cancer centers. So, if we think about what the professional organizations in cancer are doing, they're actually saying we should attend to people's mental well-being while they're going through cancer.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Recent Videos
Image of doctor with brown hair.
Image of man with black hair.
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Related Content

RELATED ARTICLES

View additional resources on CureToday.com